- Home
- PFO vs RPTX Comparison
PFO vs RPTX Comparison
Compare PFO & RPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PFO
- RPTX
- Stock Information
- Founded
- PFO 1991
- RPTX 2016
- Country
- PFO United States
- RPTX Canada
- Employees
- PFO N/A
- RPTX N/A
- Industry
- PFO Finance Companies
- RPTX Biotechnology: Pharmaceutical Preparations
- Sector
- PFO Finance
- RPTX Health Care
- Exchange
- PFO Nasdaq
- RPTX Nasdaq
- Market Cap
- PFO 116.6M
- RPTX 63.9M
- IPO Year
- PFO N/A
- RPTX 2020
- Fundamental
- Price
- PFO $9.26
- RPTX $1.54
- Analyst Decision
- PFO
- RPTX Strong Buy
- Analyst Count
- PFO 0
- RPTX 3
- Target Price
- PFO N/A
- RPTX $4.50
- AVG Volume (30 Days)
- PFO 31.8K
- RPTX 95.0K
- Earning Date
- PFO 01-01-0001
- RPTX 08-05-2025
- Dividend Yield
- PFO 6.51%
- RPTX N/A
- EPS Growth
- PFO N/A
- RPTX N/A
- EPS
- PFO N/A
- RPTX N/A
- Revenue
- PFO N/A
- RPTX $1,073,000.00
- Revenue This Year
- PFO N/A
- RPTX N/A
- Revenue Next Year
- PFO N/A
- RPTX N/A
- P/E Ratio
- PFO N/A
- RPTX N/A
- Revenue Growth
- PFO N/A
- RPTX N/A
- 52 Week Low
- PFO $6.90
- RPTX $0.89
- 52 Week High
- PFO $8.51
- RPTX $4.29
- Technical
- Relative Strength Index (RSI)
- PFO 59.15
- RPTX 65.29
- Support Level
- PFO $9.15
- RPTX $1.40
- Resistance Level
- PFO $9.37
- RPTX $1.59
- Average True Range (ATR)
- PFO 0.08
- RPTX 0.05
- MACD
- PFO -0.00
- RPTX 0.01
- Stochastic Oscillator
- PFO 65.95
- RPTX 81.82
About PFO Flaherty & Crumrine Preferred and Income Opportunity Fund Incorporated
Flaherty & Crumrine Prfd Income Oppo is the United States-based diversified, closed-end management investment company. Its primary investment objective is to provide its common shareholders with high current income consistent with the preservation of capital. The fund invests in a diversified portfolio of preferred securities which includes traditional preferred stocks eligible for the inter-corporate dividends received a deduction and fully taxable preferred securities.
About RPTX Repare Therapeutics Inc.
Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations.